These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Omics-based biomarkers: current status and potential use in the clinic. Quezada H; Guzmán-Ortiz AL; Díaz-Sánchez H; Valle-Rios R; Aguirre-Hernández J Bol Med Hosp Infant Mex; 2017; 74(3):219-226. PubMed ID: 29382490 [TBL] [Abstract][Full Text] [Related]
4. Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers. Li YC; Li KS; Liu ZL; Tang YC; Hu XQ; Li XY; Shi AD; Zhao LM; Shu LZ; Lian S; Yan ZD; Huang SH; Sheng GL; Song Y; Liu YJ; Huan F; Zhang MH; Zhang ZL Front Immunol; 2022; 13():1049812. PubMed ID: 36389727 [TBL] [Abstract][Full Text] [Related]
6. BRCAness in biliary tract cancer: a new prognostic and predictive biomarker? Hachem S; Kassis Y; Hachem MC; Zouein J; Gharios J; Kourie HR Biomark Med; 2023 Jan; 17(1):51-57. PubMed ID: 36994675 [TBL] [Abstract][Full Text] [Related]
7. A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. Wen H; Yoo SS; Kang J; Kim HG; Park JS; Jeong S; Lee JI; Kwon HN; Kang S; Lee DH; Park S J Hepatol; 2010 Feb; 52(2):228-33. PubMed ID: 20036026 [TBL] [Abstract][Full Text] [Related]
8. Bile liquid biopsy in biliary tract cancer. Liu F; Hao X; Liu B; Liu S; Yuan Y Clin Chim Acta; 2023 Nov; 551():117593. PubMed ID: 37839517 [TBL] [Abstract][Full Text] [Related]
9. Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method. Xu X; Cheng S; Ding C; Lv Z; Chen D; Wu J; Zheng S Mol Med Rep; 2015 Mar; 11(3):2191-8. PubMed ID: 25405977 [TBL] [Abstract][Full Text] [Related]
10. Novel diagnostic and prognostic biomarkers in biliary tract cancer. Skipworth JR; Timms JF; Pereira SP Expert Opin Med Diagn; 2013 Sep; 7(5):487-99. PubMed ID: 23971898 [TBL] [Abstract][Full Text] [Related]
11. Advances in biomarkers of biliary tract cancers. Hu J; Yin B Biomed Pharmacother; 2016 Jul; 81():128-135. PubMed ID: 27261586 [TBL] [Abstract][Full Text] [Related]
12. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease. Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771 [TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer. Dhar DK; Olde Damink SW; Brindley JH; Godfrey A; Chapman MH; Sandanayake NS; Andreola F; Mazurek S; Hasan T; Malago M; Pereira SP Cancer; 2013 Feb; 119(3):575-85. PubMed ID: 22864959 [TBL] [Abstract][Full Text] [Related]
15. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. Shigehara K; Yokomuro S; Ishibashi O; Mizuguchi Y; Arima Y; Kawahigashi Y; Kanda T; Akagi I; Tajiri T; Yoshida H; Takizawa T; Uchida E PLoS One; 2011; 6(8):e23584. PubMed ID: 21858175 [TBL] [Abstract][Full Text] [Related]
16. Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers. Mayr C; Beyreis M; Wagner A; Pichler M; Neureiter D; Kiesslich T Biomed Res Int; 2016; 2016():4805270. PubMed ID: 27957497 [TBL] [Abstract][Full Text] [Related]
17. Clinical impact of bile-derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers. Yoshida M; Yukawa H; Hayashi K; Naitoh I; Miyabe K; Hori Y; Natsume M; Jinno N; Kato A; Kachi K; Asano G; Sahashi H; Toyohara T; Kuno K; Kito Y; Kondo H; Hirano A; Okumura F; Anbe K; Baba Y; Kataoka H; Tanaka Y Cancer Sci; 2023 Jan; 114(1):295-305. PubMed ID: 36168845 [TBL] [Abstract][Full Text] [Related]
18. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer. Vera R; Ibarrola-de-Andrés C; Adeva J; Pérez-Rojas J; García-Alfonso P; Rodríguez-Gil Y; Macarulla T; Serrano-Piñol T; Mondéjar R; Madrigal-Rubiales B Clin Transl Oncol; 2022 Nov; 24(11):2107-2119. PubMed ID: 36008616 [TBL] [Abstract][Full Text] [Related]